Insulet
PODD
#1196
Rank
NZ$24.33 B
Marketcap
$347.12
Share price
-0.63%
Change (1 day)
14.36%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.81

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.78. In 2022 the company made an earnings per share (EPS) of $0.11 a decrease over its 2021 EPS that were of $0.37.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.812380.74%
2022$0.11-69.57%
2021$0.37109.09%
2020$0.18-38.89%
2019$0.29200%
2018$0.09698-113.04%
2017-$0.74-9.8%
2016-$0.82-60.77%
2015-$2.1039.78%
2014-$1.5012.05%
2013-$1.34-23.15%
2012-$1.7510.2%
2011-$1.58-36.36%
2010-$2.49-36.63%
2009-$3.93-29.36%
2008-$5.56-86.74%
2007-$41.94-64.04%
2006-$116.62122.23%
2005-$52.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.27-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.22-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.58-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.77 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.80 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.40 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.78 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA